London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
You’re not but my enthusiasm is tempered by the fact I’m still underwater here, albeit only just now
Am I the only person feeling good about this share atm...?
Another good start, would be nice to have a whopper rns just before Christmas..lol..gla
On Indivior's phase one study using our molecule C4X3256, hopefully good results. Gla
It looks very much like the finish of a big, badly handled seller, who has been around since the summer. Having taken price down from 40+ to sub 30 a decent bounce should be inevitable. I’d expect some RNS holdings announcements soon to identify interested parties. Buyers could be RG, could be LO. Anyway, pressure off.
Why the sudden surge out of nowhere all of a sudden?Do you think Griffiths is buying again?Surely he would do it in a bit less of a hasty fashion though.Alot of volume traded and supported with no interest for months.
Far more likely to be delayed reporting of buys rather than sells. Whether something is marked as a buy or sell is based entirely on whether it's closest to the *current* bid or ask price at the time of reporting and it doesn't always reflect what happened at the actual time of purchase.
Crazy trades as you say, the sp goes higher as the sells go higher, hope it is good news on its way, my portfolio could do with a bit of propping up.gla
I do know for a fact that this is a buy but it shows as a sell
05-Nov-21 10:07:14 33.00 2,218 Sell* 33.00 34.00 731.94 O
Im assuming for the share price to move today and most likely the big sells are buys there must be imminent news coming.
Could be a disguised buy, let's hope it is...gla
Has the seller finally finished given the huge trades earlier or are they buys !!!
Something seems to have kickstarted this into life today
Must be some news on its way, its well overdue...gla
In my experience, drug discovery companies only provide updates when they have something meaningful to communicate or if they're obligated to. That approach seems to be shared by the scientific community in general - those among them who value credibility, anyway.
Well it has been 6 months! As an investor I would expect to have received some kind of update by now as I'm sure they haven't been sat twiddling their thumbs for half a year.
I wouldn't really want to see the price jump up and down on rumours and hype. They're doing what they should be: focusing on the science rather than holding investors' hands.
Had more excitement watching paint dry.
An update is way way overdue.
C4XD and Sanofi nominated at Informa's Scrip awards (Best Partnership Alliance category)
https://pharmaintelligence.informa.com/events/awards/scrip-awards-2021/shortlist
would appear as if the £800k trade was a limit worked buy at 29.5p - the support is a lot lower than before, so at least some baseline is established. I can't say any reason why it would go up now, but also nothing for down either.
interesting times
A bit of movement today and a positive rise for once............hopefully the seller is now done. We do need news though
Hopefully.We're getting 5 trades a day at the mo.
May get a business update this week. Last year’s update was on the 25th of August !!
I think it's about right.
IIRC the start was delayed by several months due to Covid and it takes months to analyse the data. I assume they wanted proof that no volunteers reported any adverse effects for at least a couple of months after dosing. Finally, there might have been an abnormally high amount of pressure on clinical trial companies lately. Fwiw, I think they achieved their 'estimated completion' date.
Thanks.Seems weird they took so long to do that to my amateur eye and knoweldge admittedly.I'm sure it's normal though ?
I guess the rise up earlier this year and huge volume and sell on news might have been that some folk in the know could have known about the progression of the last small molecule and it had a good chance of being licenced out.
The trial results are out... kind of.
The study only gave one single dose of the drug to each patient, because all they were doing was checking to make sure there were no adverse effects.
I think the fact they're now starting a 'repeated dose' trial (see below) is a pretty clear sign the first one went well. Maybe the price drop is because the estimated completion date is another year away.
https://clinicaltrials.gov/ct2/show/NCT04976855